Based on our results, we suggest that therapeutic strategies for bladder cancer should be directed toward the ablation of NEDD4, which may potentially be clinically viable targets for the prevention, detection and treatment of bladder cancer. The gene discussed is NEDD4; the disease is urinary bladder cancer.